What to expect from upcoming MCS randomized trials?
- 10 October 2022
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 11 (11) , 841-843
Abstract
Uwe Zeymer, MD, Holger Thiele, MD; WHAT TO EXPECT FROM UPCOMING MCS RANDOMIZED TRIALS?, European Heart Journal. Acute Cardiovascular Care, , zuac124, https://doKeywords
This publication has 7 references indexed in Scilit:
- Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trialsEuropean Journal of Heart Failure, 2021
- Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trialAmerican Heart Journal, 2021
- Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trialEuroIntervention, 2021
- Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of CardiologyEuropean Heart Journal: Acute Cardiovascular Care, 2020
- Rationale and design of DanGer shock: Danish-German cardiogenic shock trialAmerican Heart Journal, 2019
- Management of cardiogenic shock complicating myocardial infarction: an update 2019European Heart Journal, 2019
- Extra Corporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock (ECMO-CS): Rationale and Design of the Multicenter Randomized TrialEuropean Journal of Heart Failure, 2017